Home › Funds › PSP Research LLC › RAPP
PSP Research LLC position in RAPP
RAPT THERAPEUTICS INC · Health Care
PSP Research LLC reported holding 14,000 shares of RAPP (RAPT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$583K, representing 0.31% of its reported portfolio and ranking #8 among its reported holdings. PSP Research LLC has disclosed RAPP holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
How PSP Research LLC's RAPP position evolved
PSP Research LLC first disclosed a stake in RAPP in Q4 2025 at 17,506 shares (US$531K). The position peaked in Q2 2026 at 14,000 shares, worth US$583K. Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 14,000 shares valued at US$583K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 17.51K | $531.13K | New |
| Q1 2026 | 14.00K | $438.06K | Reduce |
| Q2 2026 | 14.00K | $583.38K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RAPP and 13F data
RAPP (RAPT THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in RAPP — the largest reported positions include TRV GP V, LLC (US$261.7M), ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RAPP
- TRV GP V, LLC 6.28M sh · $261.71M · Q2 2026
- ARCH Venture Management, LLC 3.73M sh · $155.38M · Q2 2026
- Cormorant Asset Management, LP 2.66M sh · $110.74M · Q2 2026
- Sofinnova Investments, Inc. 1.90M sh · $79.36M · Q2 2026
- JOHNSON & JOHNSON 1.78M sh · $74.36M · Q2 2026
- BAKER BROS. ADVISORS LP 1.55M sh · $64.47M · Q2 2026
- TRV GP VI, LLC 969.22K sh · $40.39M · Q2 2026
- PERCEPTIVE ADVISORS LLC 773.34K sh · $32.23M · Q2 2026
- Vestal Point Capital, LP 730.00K sh · $30.42M · Q2 2026
- Siren, L.L.C. 641.47K sh · $26.73M · Q2 2026
- Sio Capital Management, LLC 307.66K sh · $12.82M · Q2 2026
- Burkehill Global Management, LP 250.00K sh · $10.42M · Q2 2026